Form 4: Northrop Grumman Director Sells Shares

Mark A. Welsh III, a Director at Northrop Grumman Corp, reported the sale of common stock totaling 147 shares for an aggregate price of approximately $84,000, executed under a Rule 10b5-1 trading plan.

Summary

• Mark A. Welsh III, a Director of Northrop Grumman Corp, engaged in a series of stock sales on May 4, 2026.
• A total of 147 shares of common stock were sold across multiple transactions.
• The sales were conducted under a pre-established Rule 10b5-1 trading plan adopted on August 23, 2025.
• The weighted average sale price for these transactions was approximately $570.00 per share.
• Following these transactions, Mr. Welsh III beneficially owns 4,121 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transactions were conducted under a pre-arranged trading plan, indicating a planned event rather than a reaction to new information.

Negatives

• Director Mark A. Welsh III sold a total of 147 shares of Northrop Grumman common stock.
• The sales occurred on May 4, 2026, with individual transaction prices ranging from $566.60 to $577.05.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions.

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

Industry Context

StockSavvy.ai notes that insider sales, particularly when executed under a Rule 10b5-1 plan, are common and often reflect pre-scheduled diversification or liquidity management rather than a negative view of the company's prospects. However, significant sales by directors warrant monitoring.

Stakeholder Impact

• Shareholders: The sale of shares by a director may be perceived negatively, although the execution under a Rule 10b5-1 plan mitigates concerns about insider trading based on material non-public information.

Key Dates

Keywords

Northrop Grumman, NOC, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Director Transaction, Beneficial Ownership